1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications.

Slides:



Advertisements
Similar presentations
Partners in Crime: Your Pharmacist Sarah A. Spinler, PharmD, FCCP,FAHA, FASHP, BCPS (AQ Cardiology) Professor of Clinical Pharmacy Philadelphia College.
Advertisements

Medication Administration Training
To Err Really is Human: Misunderstanding Medication Labels Terry C. Davis, PhD LSUHSC-S Ruth Parker, MD Emory University.
INDIGESTION (DYSPEPSIA) AND HEARTBURN (ACID REFLUX)
Orlistat 60 mg NDA Label Comprehension Study Joint Nonprescription Drugs Advisory Committee and Endocrine and Metabolic Drugs Advisory Committee.
KNOW THE FACTS: SERIES III 4 Steps to Using Prescription Drugs Responsibly This document is confidential and is intended solely for the use and information.
Medication Guides Nancy M. Ostrove, Ph.D. Division of Drug Marketing, Advertising, and Communications.
The FDA’s Role in Medicine Safety and Use
Health Grade 6 Understanding Drugs Mr. Vargas. Drugs and Your Health What advice would you give to a friend about how to use medicine safely?
Product Training Series
Mr. Ramos.  Objectives: ◦ Explain how to identify the two basic groups of medicine. ◦ Describe the various prescription and over-the- counter drugs.
Mr. Beerbower McHenry High School
History and Physical Health Science.
1 OTC Omeprazole Magnesium (Prilosec 1 TM ) October 20, 2000 Larry Goldkind MD Division of Gastrointestinal and Coagulation Drug Products CDER, FDA.
Joint NDAC/PAC meeting October 18, 2007 OTC Cold and Cough Products: Use in Children Advisory Committee Meeting October 18, 2007 Joel Schiffenbauer, MD.
1 Prilosec 1 Label Comprehension Studies and12179 Karen Lechter, J.D., Ph.D. FDA Division of Surveillance, Research, and Communication Support Office.
Assessing the Impact of a Toll-Free Number for Reporting Side Effects in Direct-to-Consumer Television Ads: Proposed Study Design Kathryn J. Aikin, Ph.D.
NDA/PADAC Joint Meeting Matthew R. Holman, Ph.D. Interdisciplinary Scientist FDA, CDER, Div. Of OTC Drug Products April 22,
Background *Global increase in drug consumption*Global increase in drug consumption *In 1998, Philippines ranked second to Singapore in terms of per capita.
Clinical Training: Medication Reconciliation
Direct-to-Consumer Advertising of Prescription Drugs: Looking Back, Looking Forward Kathryn J. Aikin, Ph.D. Division of Drug Marketing, Advertising and.
Medication Management – Tapping the Pharmacist’s Expertise for Employees with Multiple Medications Rosemarie Patodia, BScPhm, CGP Pharmacist, Manager,
EMPLOYEES: BE EMPOWERED START TALKING! about safe & responsible medication practices.
By Ruth Kavita Senior Pharmaceutical Technologist, KNH.
1. 2 Medicines are Drugs A medicine or drug… –changes how your body works, or –treats or prevents a disease or symptom.
Administering Medications in Southeastern California Conference Schools.
Responsibilities and Principles of Drug Administration
DRUGS AND MEDICINE Lesson 1. How Medicines Help You A drug is a substance that changes the way the body and mind works. Examples?
Pharmacists’ Expanded Scope of Practice in Canada as of Oct 2014 Source: Canadian Pharmacists Association.
Chapter 15 Personal Care and Consumer Choices Lesson 3 Using Medicines Wisely Next >> Click for: >> Main Menu >> Chapter 15 Assessment Teacher’s notes.
Using Drugs to Promote Health
Overview of medication issues and administration of medications in school Adebola E. Orimadegun.
Drugs as Medicines Coach Graner Health Class Notes.
The Responsible Use Of Drugs A drug is substance [other than food] that changes the way the body or mind works. Drug use is a term used to describe drug-
November 2012 This document was supported, in part, by grant number 90-MP0144 from the Administration on Aging, Department of Health & Human Services.
DRAFT SLIDES FOR NDA ADVISORY COMMITTEE PRESENATIONS.
DISTRICT MEDICATION RECONCILIATION AND ADMINISTRATION Adapted from Medication Reconciliation from the QSEN website Originally developed by Judy Young,
National Survey on Consumer Reaction to DTC Advertising of Prescription Medicines: Comments from DDMAC Kathryn J. Aikin, Ph.D. Division of Drug Marketing,
1 Hazard Communication 29 CFR Introduction l What is Hazard Communication? l Why are we doing it? l What do we have to do?
Using Medicines Safely (2:50) Click here to launch video Click here to download print activity.
HOW TO WRITE A PRESCRIPTION. The prescription order is an important therapeutic transaction between physician and the patient. It brings into focus the.
Mevacor Daily ® Merck NDA Nonprescription Drugs Advisory Committee and Endocrinologic and Metabolic Advisory Committee Meeting Silver Spring, Maryland.
SELECT Label Comprehension Studies Mevacor™ Daily Capt. Laura Shay, RN, MS, C-ANP Division of Nonprescription Clinical Evaluation Center for Drug Evaluation.
Summary of Issues on Urticaria as an OTC Indication Charles Ganley, M.D. Division of OTC Drug Products April 22, 2002 Non-Prescription Drug Advisory Committee.
DODAC and DSaRM Advisory Committee August 1, 2007 Pregnancy Registry and Root Cause Analysis Cynthia Kornegay, Ph.D. Division of Drug Risk Evaluation Office.
AFAMS Receive a Prescription Order (Dari) EO
Prilosec1 ® 20 mg Tablets Rx to OTC Switch Daiva Shetty, M.D. Division of Over-the-Counter Drug Products (HFD-560) Food and Drug Administration 1.
General Regulatory Issues in the Development of Drugs Intended for Treatment of Chronic Illness Sharon Hertz, M.D. Medical Officer Division of Anesthetic,
South Carolina College of Pharmacy Presenters names go here.
Adherence & the Role of Consumers & Carers in Medication Management Sue Henderson.
Evaluating Consumer Comprehension of Prescription Drug Information Saul Shiffman, Ph.D. Senior Scientific Advisor, Pinney Associates Consulting to industry.
1 DRAFT SLIDES FOR NDA ADVISORY COMMITTEE PRESENTATIONS.
Evaluation of Virginia’s Preferred Drug List: 4th Quarter Report Policy and Research Division November 2, 2004Department of Medical Assistance Services.
Pivotal Label Comprehension Study Mevacor™ OTC Capt. Laura Shay, RN, MS, C-ANP Division of Over-the-Counter Drug Products Center for Drug Evaluation and.
1 Clinical Overview Omeprazole Magnesium (Prilosec 1 TM ) June 21, 2002 Mark Avigan, MD CM Division of Gastrointestinal and Coagulation Drug Products CDER,
Jamie Bango Lindsey Croker Kristen Lantz Achidi Ndiforchu.
PATIENT SELF- ADMINISTRATION OF MEDICATION PURPOSE / POLICY Purpose: To promote correct administration of meds by patients and families/caregivers Policy:
The Quality Gateway Chapter 11. The Quality Gateway.
PHARMACIST : A HEALTH CARE PROFESSIONAL
Kamagra Fizz Usage, Dosage, Composition. Summary Kamagra is the generic form of the brand Viagra. It contains sildenafil citrate as the active component.
Medication Errors & Risk Reduction Ch. 7
PRESCRIPTIONS Chap. 5.
Chapter 5 Prescriptions.
Medication Errors: Preventing and Responding
Are condoms a contraceptive method
Using Medicines Safely (2:50)
Using Medications Wisely Consumer Education Update
Ch 18: Pharmacy.
Prescription vs. OTC.
Prescription Drugs.
Presentation transcript:

1 Prilosec Label Comprehension Study Karen Lechter, J.D., Ph.D. Division of Drug Marketing, Advertising, and Communications

2 Purpose of Label Comprehension Studies 21 CFR (a)(4)(v) [OTC labels shall be written] in such terms as to render them likely to be read and understood by the ordinary individual, including individuals of low comprehension, under customary conditions of purchase and use.

3 Main Study Characteristics Mall intercept N=504 Male and female >age 18

4 Main Study Characteristics 4 cohorts: 1. heartburn sufferers (N=197) 2. heartburn non-sufferers (N=104) 3. low literate (<8th grade reading) [N (sufferers) =101; N (non-sufferers) =54)] 4. must ask doctor before use (N=117) --take certain meds., pregnant, nursing

5 Product Purpose When asked purpose of product: 99% prevention or relief or both –65% relief –18% prevention –16% prevention and relief Label says prevention and relief

6 Do Consumers Understand? What to do after 14 days of use (83%) What to do if trouble swallowing (81%) When take to prevent if expect stress (80%) When take to prevent if expect meal (83%) –Low literate (75%) If can take 2 within 24 hours (2 Q’s) (81%, 83%) –Low literate (74%, 81%)

7 Troubling Result 74% of cohort 4 (should see doctor before use) incorrectly said they would use the product to prevent and relieve (2Q’s) 21% correct--would not use

8 Addendum Study Does wording of question about self-use in cohort 4 contribute to incorrect responses? Compared responses to original self- use question with new self-use question N=58 (29 in each arm) All should ask doctor before use: –pregnant, nursing, taking certain drugs

9 Addendum Study Questions Original questions: If you wanted to prevent/relieve heartburn, would you use Prilosec 1 yourself? New questions: If you were a heartburn sufferer and you wanted to prevent/relieve heartburn, would it be okay for you (,personally,) to use Prilosec 1 yourself, or not?

10 Addendum Study Results % correct prevention relief Original Question35%31% Reworded Question69%59% Even with the reworded question, comprehension is low

11 Additional Addendum Study Questions If prior response is incorrect: Is there anything you would do prior to taking this product, or not? If prior response is incorrect: Considering your current health and medications you are currently taking, would it be necessary for you to contact a doctor prior to using this product yourself, or not?

12 Additional Addendum Study Questions If prior response is incorrect: Are you currently taking any of the following medications? diazepam, warfarin, phenytoin If prior response is incorrect: Are you currently taking any of the following medications?Valium, Coumadin, Dilantin Results of leading questions have uncertain value

13 Addendum Study Conclusions Group that should consult with physician before use demonstrates problems in both studies 59%-69% correct responses to new question

14 Tested Label vs. NDA Label Label changed substantially after label comprehension test New label not tested

15 Tested Label vs. NDA Label NDA label added – Causes of symptoms for prevention – Allergy warning – “Do not use” section – Do not use with acid reducers – New drugs to ask about – Wording about taking for prevention – Amount of water to drink

16 Tested Label vs. NDA Label NDA label Specified # days after which see doctor Changed 14 day limit to 10 days Ask pharmacist as well as doctor about drugs Changed wording: trouble swallowing, pregnancy, directions, storage instructions Reversed--relief and prevention indications and directions Bolded and added warning symbol to instruction not to take more than 10 days

17 NDA Label NDA Label was not tested

18 Summary Consumers associate product with relief –65% said it is for relief Data suggest potential for substantial use by persons who should consult doctor first Some information is not strongly communicated Most recent label not tested –Differs significantly from tested label